China has blocked Meta’s approximately $2 billion acquisition of the agentic AI startup Manus, ordering both parties to withdraw from the deal, according to multiple verified reports. The move, announced on April 27, 2026, underscores intensifying regulatory scrutiny of high-stakes cross-border tech transactions.
Regulatory Intervention and Deal Details
The decision was issued by China’s National Development and Reform Commission (NDRC), which instructed that the acquisition transaction must be unwound, citing compliance with Chinese laws and regulations—a rare post-completion reversal of a foreign acquisition.
This follows Meta’s December 2025 announcement to acquire Manus, a Singapore-based AI startup with roots in China, in a transaction reportedly valued at approximately $2 billion, to integrate its AI agent technology into Meta AI products, according to TechCrunch and Wikipedia’s summary of multiple sources.
Background on Manus and Regulatory Concerns
Manus was originally founded in China by the Beijing-based entity Butterfly Effect before relocating its headquarters to Singapore in mid‑2025, according to Wikipedia. Despite the shift, its Chinese origin and lingering ties—including remaining ownership and executive presence—drew regulatory scrutiny.
In March, Chinese authorities reportedly imposed exit bans on Manus’s CEO Xiao Hong and Chief Scientist Ji Yichao during an ongoing review of the deal, as noted by TechCrunch and other outlets.
Meta’s Response and Geopolitical Dimensions
Meta stated that the transaction complied fully with applicable law and expressed anticipation of an appropriate resolution, according to Reuters, AP, TechCrunch, and others.
Observers interpret China’s decision as part of a broader defensive posture to retain domestic AI capabilities and impose conditions on foreign acquisitions, especially amid rising U.S.–China tensions over advanced technology control.
Implications and Outlook
This intervention signals to tech leaders and investors that even relocations to non‑China jurisdictions may not shield transactions from Beijing’s oversight, especially for AI firms with origins in China.
The unfolding situation raises questions about how Meta might practically unwind the deal—considering employee relocation, integration efforts, intellectual property transfer, and business operations already in motion.
Conclusion
China’s directive to reverse Meta’s acquisition of Manus represents a striking assertion of regulatory authority in the global AI sector. As Meta works to navigate this setback, the case sets a cautionary precedent for future cross‑border AI deals amid geopolitical competition.